Hutch News

Hutch News

Stories tagged 'SWOG'

Finasteride can reduce prostate cancer risk long term

Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss

March 21, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch public health researcher Dr. Joe Unger used an innovative trial design to confirm finasteride, a drug used to treat enlarged prostate or hair loss in men, has a long-term protective effect against prostate cancer.

View story >


Acupuncture can curb treatment-related joint pain in breast cancer patients

Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug

Dec. 7, 2017 | By Diane Mapes / Fred Hutch News Service

Results from a large multicenter trial released Thursday at the San Antonio Breast Cancer Symposium offer good news to early stage breast cancer patients dealing with painful side effects from powerful estrogen-squelching drugs known as aromatase inhibitors.

View story >


Matching up cancer risk with reality

New examination of prostate cancer data identifies ‘detection bias’ in prostate studies

Oct. 31, 2016 | By Diane Mapes / Fred Hutch News Service

A new Fred Hutch-led study suggests variation in prostate cancer biopsy patterns, i.e., who does and who doesn't get screened, may have colored our perception of risk for the disease.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 2, 2016

Global Oncology wins NCI grant; 1100 Eastlake Building honored; Bish Paul pens essay in Science; Dr. Joseph Unger leads finasteride study.

View story >


Improving survival and reducing side effects in Hodgkin lymphoma

New data from cooperative trial suggest PET imaging could guide treatment

April 11, 2016 | By Susan Keown / Fred Hutch News Service

This personalized-treatment strategy for advanced Hodgkin lymphoma saved patients who responded to standard chemo from the toxicities of a more aggressive regimen.

View story >


In defense of the negative result

Large cancer clinical trials that ‘fail’ carry just as much scientific oomph as positive findings, new study shows

March 10, 2016 | By Rachel Tompa / Fred Hutch News Service

Researchers have found a positive side to negative results in cancer clinical trials -- among all the publications resulting from large cancer clinical trials, negative trials have just as much scientific impact as positive findings.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.